Gemcitabine combined with gum mastic causes potent growth inhibition and apoptosis of pancreatic cancer cells

Aim: To investigate the antiproliferative and apoptotic effects of gemcitabine combined with gum mastic and the underlying mechanisms in human pancreatic cancer cell lines. Methods: Cell proliferation and apoptosis were examined using the methyl thiazolyl tetrazolium (MTT) assay and propidium iodine...

Full description

Saved in:
Bibliographic Details
Published inActa pharmacologica Sinica Vol. 31; no. 6; pp. 741 - 745
Main Authors Huang, Xin-yu, Wang, Hong-cheng, Yuan, Zhou, Li, Ang, He, Mei-lan, Ai, Kai-xing, Zheng, Qi, Qin, Huan-long
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.06.2010
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aim: To investigate the antiproliferative and apoptotic effects of gemcitabine combined with gum mastic and the underlying mechanisms in human pancreatic cancer cell lines. Methods: Cell proliferation and apoptosis were examined using the methyl thiazolyl tetrazolium (MTT) assay and propidium iodine staining, respectively. The expression of Bcl-2, Bax, NF-KB p65 subunit, and IKBC( protein was measured using Western blotting. Results: Gemcitabine 0.01-100 pg/mL inhibited cell proliferation and induced apoptosis in both pancreatic cancer BxPC-3 and COLO 357 cells. Gum mastic 40 pg/mL significantly potentiated the antiproliferative and apoptotic effects of gemcitabine 10 μg/mL after 72-h treatment. When cells were treated with gemcitabine in combination with gum mastic, the IKBα level was increased, whereas NF-κB activation was blocked; the expression of Bax protein was substantially increased, but Bcl-2 protein was down-regulated. Conclusion: Gemcitabine combined with gum mastic causes potent apoptosis in pancreatic cancer cells. The combination may be an effective therapeutic strategy for pancreatic cancer.
Bibliography:Bcl-2
pancreatic cancer
Q255
gum mastic
Bax
gemcitabine; gum mastic; pancreatic cancer; apoptosis; NF-kappaB; Bcl-2; Bax
apoptosis
gemcitabine
NF-kappaB
Q813
31-1347/R
These authors contributed equally to the article.
ISSN:1671-4083
1745-7254
DOI:10.1038/aps.2010.54